CALISTOGA PHARMACEUTICALS

calistoga-pharmaceuticals-logo

Calistoga Pharmaceuticals, Inc. is the leader in developing innovative oral medicines targeting selected isoforms of the PI3 kinase pathway to improve the health of patients with cancer and inflammatory diseases. The PI3K pathway is a critical cellular pathway involved in cell survival and immune cell activation. Calistoga Pharmaceuticals' small-molecule therapeutic candidates inhibit specific isoforms of the PI3K pathway, providing a targeted treatment approach designed to maximize clinical... outcome and limit unwanted side effects. Calistoga Pharmaceuticals' lead product, CAL-101, an oral delta-isoform selective PI3K inhibitor, has demonstrated promising clinical responses in patients with B-cell malignancies and is currently being evaluated in multiple clinical trials. In addition to CAL-101, Calistoga Pharmaceuticals' product development pipeline includes other selective PI3K inhibitors in early preclinical development or ready for initial clinical trials in patients with cancer or inflammatory diseases.

#SimilarOrganizations #People #Financial #Website #More

CALISTOGA PHARMACEUTICALS

Social Links:

Industry:
Alternative Medicine Biotechnology Medical

Founded:
2006-01-01

Address:
Seattle, Washington, United States

Country:
United States

Website Url:
http://www.calistogapharma.com

Total Employee:
1+

Status:
Active

Contact:
07804443213

Total Funding:
97.2 M USD

Technology used in webpage:
SPF Mobile Non Scaleable Content Amazon Amazon Virginia Region NameBright Citrix NetScaler StatCounter


Similar Organizations

epicyte-pharmaceuticals-logo

Epicyte Pharmaceuticals

Epicyte Pharmaceutical is focused on development therapeutic monoclonal antibodies for cancer, infectious and inflammatory diseases.

kindex-pharmaceuticals-logo

KinDex Pharmaceuticals

KinDex Pharmaceuticals is a developer of novel therapeutics used to help patients suffering from metabolic disorders.

Current Employees Featured

michael-gallatin_image

Michael Gallatin
Michael Gallatin President @ Calistoga Pharmaceuticals
President

james-topper_image

James Topper
James Topper Co-Founder @ Calistoga Pharmaceuticals
Co-Founder

neill-giese_image

Neill Giese
Neill Giese CSO @ Calistoga Pharmaceuticals
CSO
2006-01-01

Founder


james-topper_image

James Topper

Investors List

latterell-venture-partners_image

Latterell Venture Partners

Latterell Venture Partners investment in Series C - Calistoga Pharmaceuticals

amgen-ventures_image

Amgen Ventures

Amgen Ventures investment in Series C - Calistoga Pharmaceuticals

alta-partners_image

Alta Partners

Alta Partners investment in Series C - Calistoga Pharmaceuticals

quogue-capital_image

Quogue Capital

Quogue Capital investment in Series C - Calistoga Pharmaceuticals

three-arch-partners_image

Three Arch Partners

Three Arch Partners investment in Series C - Calistoga Pharmaceuticals

frazier-healthcare-ventures_image

Frazier Healthcare Partners

Frazier Healthcare Partners investment in Series C - Calistoga Pharmaceuticals

alta-partners_image

Alta Partners

Alta Partners investment in Series B - Calistoga Pharmaceuticals

frazier-healthcare-ventures_image

Frazier Healthcare Partners

Frazier Healthcare Partners investment in Series B - Calistoga Pharmaceuticals

amgen-ventures_image

Amgen Ventures

Amgen Ventures investment in Series B - Calistoga Pharmaceuticals

three-arch-partners_image

Three Arch Partners

Three Arch Partners investment in Series B - Calistoga Pharmaceuticals

Official Site Inspections

http://www.calistogapharma.com

  • Host name: lb-182-253.above.com
  • IP address: 103.224.182.253
  • Location: Australia
  • Latitude: -33.494
  • Longitude: 143.2104
  • Timezone: Australia/Sydney

Loading ...

More informations about "Calistoga Pharmaceuticals" on Search Engine